Skip to main content
Premium Trial:

Request an Annual Quote

Vanderbilt to Lead $4M PGx Project to Identify HIV Drug Response Markers

NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases has granted just over $4 million to a Vanderbilt University-led study to identify genetic variations that may predict how individuals will respond to HIV therapies.
 
Researchers will use the five-year grant to identify genetic markers that can predict both efficacy and toxicity of frequently prescribed HIV medications, David Haas, director of the Vanderbilt AIDS Clinical Trials Program and principal investigator on the project, explained in a statement.
 
Under the program, called “Pharmacogenomics of HIV Therapy,” Vanderbilt Medical Center will receive $2.4 million; Harvard University’s School of Public Health will receive $368,000; Massachusetts General Hospital will get nearly $1.1 million; $186,000 will go to researchers at Cornell University/Weill Cornell Medical College; and the University of Western Ontario will receive $23,000.
 
The project will use DNA samples and data from HIV-infected patients from clinical trials in Haiti and in South Africa and will focus on genes that are involved in drug metabolism and transport.
 
Another goal of the project is to assess the cost effectiveness of genetic tests in helping doctors select the most useful HIV drugs with the fewest side effects.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.